Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.

In Small (Weinheim an der Bergstrasse, Germany)

Exosomes are promising new biomarkers for colorectal cancer (CRC) diagnosis, due to their rich biological fingerprints and high level of stability. However, the accurate detection of exosomes with specific surface receptors is limited to clinical application. Herein, an exosome enrichment platform on a 3D porous sponge microfluidic chip is constructed and the exosome capture efficiency of this chip is ≈90%. Also, deep mass spectrometry analysis followed by multi-level expression screenings revealed a CRC-specific exosome membrane protein (SORL1). A method of SORL1 detection by specific quantum dot labeling is further designed and the ensemble classification system is established by extracting features from 64-patched fluorescence images. Importantly, the area under the curve (AUC) using this system is 0.99, which is significantly higher (p < 0.001) than that using a conventional biomarker (carcinoembryonic antigen (CEA), AUC of 0.71). The above system showed similar diagnostic performance, dealing with early-stage CRC, young CRC, and CEA-negative CRC patients.

Li Peilong, Chen Jiaci, Chen Yuqing, Song Shangling, Huang Xiaowen, Yang Yang, Li Yanru, Tong Yao, Xie Yan, Li Juan, Li Shunxiang, Wang Jiayi, Qian Kun, Wang Chuanxin, Du Lutao

2023-Feb-17

artificial intelligence, biomarkers, cancer, exosomes, microfluidic chips